Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Rosing

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Thrombosis and Haemostasis|June 5, 2018
Factor V Has Anticoagulant Activity in Plasma in the Presence of TFPIα: Difference between FV1 and FV2Peter van Doorn, Jan Rosing, Connie Duckers, et al.
Blood|August 13, 2008
Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiencyConnie Duckers, Paolo Simioni, Luca Spiezia, et al.
Obstetrics and Gynecology|February 2, 2008
Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trialJulia V Johnson, Jane Lowell, Gary J Badger, et al.
Thrombosis and Haemostasis|January 12, 2010
Thrombin generation as an intermediate phenotype for venous thrombosisOlivier Segers, René van van Oerle, Hugo ten ten Cate, et al.
The Journal of Biological Chemistry|April 14, 2007
Expression of allosteric linkage between the sodium ion binding site and exosite I of thrombin during prothrombin activationHeather K Kroh, Guido Tans, Gerry A F Nicolaes, et al.
Contraception|March 11, 2009
Sex hormone-binding globulin: an adequate surrogate marker for venous thromboembolism in women using new hormonal contraceptivesHuib A A M van Vliet, Frits R Rosendaal, Jan Rosing, et al.
The Journal of Biological Chemistry|July 22, 2004
An antibody specific for coagulation factor IX enhances the activity of the intrinsic factor X-activating complexRandolf J Kerschbaumer, Klaudia Riedrich, Martina Kral, et al.
The Journal of Biological Chemistry|September 20, 2007
The role of thrombin exosites I and II in the activation of human coagulation factor VKenneth Segers, Björn Dahlbäck, Paul E Bock, et al.
Thrombosis and Haemostasis|September 28, 2002
Reduced factor V concentration and altered FV1/FV2 ratio do not fully explain R2-associated APC-resistanceJosé W P Govers-Riemslag, Elisabetta Castoldi, Gerry A F Nicolaes, et al.
Blood|May 6, 2003
The APC-independent anticoagulant activity of protein S in plasma is decreased by elevated prothrombin levels due to the prothrombin G20210A mutationRory R Koenen, Guido Tans, René van Oerle, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Thrombosis and Haemostasis|June 5, 2018
Factor V Has Anticoagulant Activity in Plasma in the Presence of TFPIα: Difference between FV1 and FV2Peter van Doorn, Jan Rosing, Connie Duckers, et al.
Blood|August 13, 2008
Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiencyConnie Duckers, Paolo Simioni, Luca Spiezia, et al.
Obstetrics and Gynecology|February 2, 2008
Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trialJulia V Johnson, Jane Lowell, Gary J Badger, et al.
Thrombosis and Haemostasis|January 12, 2010
Thrombin generation as an intermediate phenotype for venous thrombosisOlivier Segers, René van van Oerle, Hugo ten ten Cate, et al.
The Journal of Biological Chemistry|April 14, 2007
Expression of allosteric linkage between the sodium ion binding site and exosite I of thrombin during prothrombin activationHeather K Kroh, Guido Tans, Gerry A F Nicolaes, et al.
Contraception|March 11, 2009
Sex hormone-binding globulin: an adequate surrogate marker for venous thromboembolism in women using new hormonal contraceptivesHuib A A M van Vliet, Frits R Rosendaal, Jan Rosing, et al.
The Journal of Biological Chemistry|July 22, 2004
An antibody specific for coagulation factor IX enhances the activity of the intrinsic factor X-activating complexRandolf J Kerschbaumer, Klaudia Riedrich, Martina Kral, et al.
The Journal of Biological Chemistry|September 20, 2007
The role of thrombin exosites I and II in the activation of human coagulation factor VKenneth Segers, Björn Dahlbäck, Paul E Bock, et al.
Thrombosis and Haemostasis|September 28, 2002
Reduced factor V concentration and altered FV1/FV2 ratio do not fully explain R2-associated APC-resistanceJosé W P Govers-Riemslag, Elisabetta Castoldi, Gerry A F Nicolaes, et al.
Blood|May 6, 2003
The APC-independent anticoagulant activity of protein S in plasma is decreased by elevated prothrombin levels due to the prothrombin G20210A mutationRory R Koenen, Guido Tans, René van Oerle, et al.
Pageof 8